Kamyar Kalantar-Zadeh

From Wikipedia, the free encyclopedia

Kamyar Kalantar-Zadeh (born October 1963) is a US American physician doing research in nephrology, kidney dialysis, nutrition, and epidemiology. He is best known as a specialist in kidney disease nutrition and chronic kidney disease and for his hypothesis about the longevity of individuals with chronic disease states, also known as reverse epidemiology including obesity paradox. According to this hypothesis, obesity or hypercholesterolemia may counterintuitively be protective and associated with greater survival in certain groups of people, such as elderly individuals, dialysis patients, or those with chronic disease states and wasting syndrome (cachexia), whereas normal to low body mass index or normal values of serum cholesterol may be detrimental and associated with worse mortality. Kalantar-Zadeh is also known for his expertise in kidney dialysis therapy, including incremental dialysis, as well as renal nutrition. He is the brother of Kourosh Kalantar-zadeh, who is an Australian scientist involved in research in the fields of materials sciences, nanotechnology, and transducers.

Kalantar-Zadeh received his education in medicine from the University of Bochum and University of Bonn (Germany) and his M.D. degree from the University of Erlangen-Nuremberg (Germany).[1] In addition, he obtained a master's degree in public health (Master of Public Health, MPH) and a PhD in epidemiology from the University of California, Berkeley.[1] He is a practicing triple board certified physician specialist in internal medicine, pediatrics, and nephrology.[1] Kalantar-Zadeh completed his residency at the State University of New York and his nephrology fellowship at the University of California, San Francisco.[1]

Career

References

Related Articles

Wikiwand AI